Showing posts with label genome. Show all posts
Showing posts with label genome. Show all posts
Thursday, May 24, 2018
Incorporating DNA Sequencing Into Primary Care
Are You And Your Primary Care Doc Ready To Talk About Your DNA? by Michelle Andrews. Kaiser Health News. May 22, 2018.
Friday, March 20, 2015
Ban Sought On Method To Edit Human Heredity
Scientists Seek Ban On Method Of Editing The Human Genome by Nicholas Wade. The New York Times. March 19, 2015.
Monday, November 11, 2013
23andMe Genetic Analysis Firm Aims To Revolutionize The Healthcare Industry
Anne Wojcicki Is The Most Daring CEO In America. Fast Company. November 2013.
(1) According to a venture capitalist quoted in the article sales of genetic analysis kits is not the ultimate objective of 23andMe. Instead once the data from this analysis is obtained, 23andMe can become the _____________ of personalized health care.
(2) The genetic data gathered could be extremely valuable to ______________________.
(3) The company has collected data from 10,000 people with _______________, the world's largest ____________ community for genetic research.
(4) According to recent survey sited in the article ________% of internists from academic medical centers deemed their knowledge of genetics as "very/somewhat poor."
(5) A group of geneticists, lawyers, bioethics experts and social scientists are working on grants to develop a personal___________________ for ________________.
(1) According to a venture capitalist quoted in the article sales of genetic analysis kits is not the ultimate objective of 23andMe. Instead once the data from this analysis is obtained, 23andMe can become the _____________ of personalized health care.
(2) The genetic data gathered could be extremely valuable to ______________________.
(3) The company has collected data from 10,000 people with _______________, the world's largest ____________ community for genetic research.
(4) According to recent survey sited in the article ________% of internists from academic medical centers deemed their knowledge of genetics as "very/somewhat poor."
(5) A group of geneticists, lawyers, bioethics experts and social scientists are working on grants to develop a personal___________________ for ________________.
Saturday, August 10, 2013
Unforeseen Consequences Of Sharing DNA
Would You Post Your DNA On Facebook? by Quentin Fottrell. August 10, 2013.
(1) Genealogy companies "operate in a legal gray area." "They're not quite _________ and they are not quite _________________.
(2) Even if a genealogy company has a privacy policy stating that will not sell the DNA, they are still subject to ______________.
(3) Inviting third parties to use DNA in internal research may not violate _______________.
(4) "Reverse identify" means _____________________.
(5) An MIT scientist stated that "we don't know what exactly _____________________.
(6)
(1) Genealogy companies "operate in a legal gray area." "They're not quite _________ and they are not quite _________________.
(2) Even if a genealogy company has a privacy policy stating that will not sell the DNA, they are still subject to ______________.
(3) Inviting third parties to use DNA in internal research may not violate _______________.
(4) "Reverse identify" means _____________________.
(5) An MIT scientist stated that "we don't know what exactly _____________________.
(6)
Friday, August 2, 2013
Networks Of Gene Interactions May Be Key To Disease Understanding and Treatment
Genetics: More Than Merely A Mutated Gene. Science Daily. August 1, 2013.
(1) Subtle differences in an individual's genome, called the ______________, can also affect how mutations are manifest.
(2) In fruit flies it was found that genetic background affected the outcomes of interactions between genetic mutations about ________ percent of the time.
(3) The genetic background may help why some people benefit from ______________ while others do not.
(1) Subtle differences in an individual's genome, called the ______________, can also affect how mutations are manifest.
(2) In fruit flies it was found that genetic background affected the outcomes of interactions between genetic mutations about ________ percent of the time.
(3) The genetic background may help why some people benefit from ______________ while others do not.
Monday, February 4, 2013
New Tool For Interpretation of Genomic Information
Genomic Analysis, The Office Edition by Anne Eisenberg. The New York Times. February 2, 2013.
With the cost of sequencing a person's genome is falling, the problem of analysis of genomic data becomes more acute. A new product by Knome, co-founded by genetic pioneer Dr. George Upchurch, has developed a product the size of a file cabinet for $125,000. While the expertise required to read the results of even this device may exceed that of "your neighborhood doctor," progress is being made toward that goal.
With the cost of sequencing a person's genome is falling, the problem of analysis of genomic data becomes more acute. A new product by Knome, co-founded by genetic pioneer Dr. George Upchurch, has developed a product the size of a file cabinet for $125,000. While the expertise required to read the results of even this device may exceed that of "your neighborhood doctor," progress is being made toward that goal.
Friday, December 28, 2012
Genomic Data Converted to Medically Relevant Report by Firm's Software
Knome Software Makes Sense of the Genome by Susan Young. Technology Review. June 12, 2012.
While costs of sequencing technology has fallen sharply, effective medical use of genomic data is still limited by the vastness of the data generated. Knome has produced a way to cut through the data by considering disease type, the pattern of inheritance, and the effects of mutations while protecting patient privacy.
While costs of sequencing technology has fallen sharply, effective medical use of genomic data is still limited by the vastness of the data generated. Knome has produced a way to cut through the data by considering disease type, the pattern of inheritance, and the effects of mutations while protecting patient privacy.
Tuesday, December 11, 2012
Forensic Microbiology Identifies Source of Major Hospital Infection: North America
Cause Of The Global Epidemic Of Clostridium Difficle Identified. MNT--Medical News Today. December 10, 2012.
Researchers from the Wellcome Trust Sanger Institute and the London School of Hygiene and Tropical Medicine have established a database for researchers to trace the genomic changes in C. difficile outbreaks. They have traced C. difficile betwen 2002 and 2006 to two epidemic strains that emerged in North American and spread rapidly between hospitals around the world. By using techniques of forensic microbiology researchers hope to trace the evolution of drug resistance in hospital and clinical settings.
Researchers from the Wellcome Trust Sanger Institute and the London School of Hygiene and Tropical Medicine have established a database for researchers to trace the genomic changes in C. difficile outbreaks. They have traced C. difficile betwen 2002 and 2006 to two epidemic strains that emerged in North American and spread rapidly between hospitals around the world. By using techniques of forensic microbiology researchers hope to trace the evolution of drug resistance in hospital and clinical settings.
Thursday, November 1, 2012
DNA Variation And Disease: One Step to Understanding the Link
Scientists Expand Catalog of Human Genetic Variation by Eryn Brown. Los Angeles Times. October 31, 2012.
By sequencing the DNA of 1092 people from 14 populations, scientist of the 1000 Genomes Project have identified over 38 million DNA variants. These variants could be key to understanding the genetic correlates of disease. In the future the variants could provide a first level check to determine a possible genetic cause to the disease.
Another account at
Personalized Medicine Moves Closer by Robert Lee Hotz. The Wall Street Journal. October 31, 2012
By sequencing the DNA of 1092 people from 14 populations, scientist of the 1000 Genomes Project have identified over 38 million DNA variants. These variants could be key to understanding the genetic correlates of disease. In the future the variants could provide a first level check to determine a possible genetic cause to the disease.
Another account at
Personalized Medicine Moves Closer by Robert Lee Hotz. The Wall Street Journal. October 31, 2012
Subscribe to:
Posts (Atom)